Category Archives: PathXL
![pathxl logo](https://www.crescentcapital.co.uk/wp-content/uploads/2017/03/pathxl-360x240.jpg)
PathXL: Belfast-based medical software firm sold to Philips
BELFAST, 21 June 2016. The Belfast-based digital pathology firm, PathXL, has been sold to the multinational health technology company,... Find Out More![pathxl logo](https://www.crescentcapital.co.uk/wp-content/uploads/2017/03/pathxl-360x240.jpg)
PathXL wins UTV Business Eye R&D Award
BELFAST, NORTHERN IRELAND – 23 October 2014. Crescent portfolio company, PathXL, won the Research & Development Project category at... Find Out More![pathxl logo](https://www.crescentcapital.co.uk/wp-content/uploads/2017/03/pathxl-360x240.jpg)
PathXL Wins Three Major Cancer Centers in the US
BELFAST, NORTHERN IRELAND, 7 October 2014: Mayo Clinic, Cleveland Clinic and UCLA are three of the latest organizations to... Find Out More![](https://www.crescentcapital.co.uk/wp-content/uploads/2014/10/PathXL-logo-simple.jpg)
Xplore launched in North America and Europe
PathXL launches PathXL Xplore, sparking a new era for digital pathology workflow systems BELFAST, NORTHERN IRELAND... Find Out More![](https://www.crescentcapital.co.uk/wp-content/uploads/2014/10/PathXL-logo-simple.jpg)
PathXL wins top Frost and Sullivan Image Analysis Award with TissueMark
Frost and Sullivan selects PathXL’s TissueMark as winner of the 2014 European New Product Innovation Award for Automated Image... Find Out More![](https://www.crescentcapital.co.uk/wp-content/uploads/2013/11/deloitte-pathxl-winner.jpg)